Koers Compass Biotechnologies, Inc. Other OTC
Aandelen
US20452Q1031
Farmaceutische producten
Omzet 2018 | - | Omzet 2019 | - | Marktkapitalisatie | 158K 145K |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | - 0 | Nettowinst (verlies) 2019 | - 0 | EV/omzet 2018 | - |
Nettoschuld 2018 | 516K 476K | Nettoschuld 2019 | 480K 443K | EV/omzet 2019 | - |
K/w-verhouding 2018 |
-2,59
x | K/w-verhouding 2019 |
-3,95
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18-04-20 |
Mathew Knowles
SAM | Sales & Marketing | - | 22-07-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18-04-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,29% | 6,02 mld. | |
-21,28% | 4,19 mld. | |
+4,52% | 3,25 mld. | |
-18,16% | 2,87 mld. | |
-7,70% | 2,37 mld. | |
+41,50% | 1,89 mld. | |
-4,05% | 1,58 mld. | |
-15,56% | 1,54 mld. | |
-14,62% | 1,5 mld. |